The KHENERGY Study: Safety and Efficacy of KH 176 in Mitochondrial m.3243A>G Spectrum Disorders-Reference-Cited by-同舟云学术

The KHENERGY Study: Safety and Efficacy of KH 176 in Mitochondrial m.3243A>G Spectrum Disorders

Published:2018-09-03 Issue:1 Volume:105 Page:101-111
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Janssen Mirian C.H.¹²,Koene Saskia¹,Laat Paul¹,Hemelaar Pleun³,Pickkers Peter³,Spaans Edwin⁴,Beukema Rypko⁵,Beyrath Julien⁴,Groothuis Jan⁶,Verhaak Chris⁷,Smeitink Jan⁴

Affiliation:

1. Department of PediatricsRadboud Center for Mitochondrial MedicineRadboud Institutes for Molecular Life Sciences and Health SciencesRadboud University Medical Center Nijmegen Nijmegen The Netherlands

2. Department of Internal MedicineRadboud Center for Mitochondrial MedicineRadboud Institutes for Molecular Life Sciences and Health SciencesRadboud University Medical Center Nijmegen Nijmegen The Netherlands

3. Department of Intensive CareRadboud University Medical Center Nijmegen Nijmegen The Netherlands

4. Khondrion BV Nijmegen The Netherlands

5. Department of CardiologyRadboud University Medical Center Nijmegen Nijmegen The Netherlands

6. Department of RehabilitationRadboud Center for Mitochondrial MedicineRadboud Institutes for Molecular Life Sciences and Health SciencesRadboud University Medical Center Nijmegen Nijmegen The Netherlands

7. Department of PsychologyRadboud Center for Mitochondrial MedicineRadboud Institutes for Molecular Life Sciences and Health SciencesRadboud University Medical Center Nijmegen Nijmegen The Netherlands

Funder

Khondrion BV

ZonMW PMRare

Foundations Energy4All

Join4Energy

Road4Energy

Ride4Kids

Tim Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology